Food Safety Bill

Food Safety Bill Threatens Natural Health Options House Bill HR 2479 – Criminal Sanctions fact sheet The FDA Food Safety Modernization Act still contains dangerous provisions that threaten access to natural health options. The FDA Food Modernization Act (S. 510), also referred to as the “Food Safety” bill, has been modified to exempt dietary supplements from […]

Read More

Food Safety

Food Safety Bill Threatens Natural Health Options The FDA Food Safety Modernization Act contains dangerous provisions that threaten access to natural health options. Most worrisome, the senate bill (S. 510) contains a reference to Codex Alimentarius. Senator Hatch has made clear to ANH-USA that the call to ask FDA to review Codex standards does not […]

Read More

Oral versus Transdermal Estrogen

JAm Coll Carddiol. 2003 Apr 16;41(8):1358-63. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I. Donald W. Reynolds Cardiovascular Clinical Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75390, USA. [email protected] OBJECTIVES: […]

Read More

Principal Results From the Women’s Health Initiative

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women Principal Results From the Women’s Health Initiative Randomized Controlled Trial Writing Group for the Women’s Health Initiative Investigators JAMA. 2002;288:321-333. Context Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain. Objective To […]

Read More

Dangerous side effects Of FDA-approved hormone therapies

FDA-approved hormone therapies have been associated with dangerous side effects. Principal Results From the Women’s Health Initiative: This study found that therapy using conjugated equine estrogens and medroxyprogesterone (neither bio-identical) were associated with increased risk of breast cancer, stroke, blood clot in the lungs, and heart disease. Risk of hip fracture and colorectal cancer were […]

Read More

Estriol and Urinary Tract Infections

Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993 Sep 9;329(11):753-6. BACKGROUND. Recurrent urinary tract infections are a problem for many postmenopausal women. Estrogen replacement restores atrophic mucosa, lowers vaginal pH, and may prevent urinary tract infections. METHODS. We enrolled 93 […]

Read More

Estriol and Urogenital Aging Symptoms

Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause. 2004 Jan-Feb;11(1):49-56. Department of Pharmacology, Gynecology and Obstetrics, University of Sassari, Sassari, Italy. [email protected] OBJECTIVE: To assess the efficacy and safety of intravaginal estriol administration on urinary […]

Read More

Estriol, Atherosclerosis and Nitric Oxide

Kano H, Hayashi T, Sumi D, Matusi-Hirai H, Tsunekawa T, Endo H, Iguchi A. Estriol retards and stabilizes atherosclerosis through an NO-mediated system. Life Sci. 2002 May 24;71(1):31-42. Department of Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan Estriol (E3) has little effect on the female genitals. E3 is used in hormone replacement therapy, […]

Read More